The FDA’s outside panel of vaccine experts largely agreed for the need to tailor future COVID-19 vaccines during a virtual meeting April 6, though the exact path and timeline to do so is still unclear, according to NPR.
Category: Public Health
A Shortfall of ECMO Treatment Cost Lives During the Delta Surge
About 50% of the covid-19 patients who got the last-ditch life support treatment at Vanderbilt University Medical Center died. Researchers wanted to know what happened to the many patients they had to turn away because ECMO (extracorporeal membrane oxygenation) machines and the specialized staffers needed were in short supply. The grim answer: 90% of those turned away perished.
Why Black and Hispanic Seniors Are Left With a Less Powerful Flu Vaccine
Federal health officials haven’t taken a clear position on whether a high-dose influenza vaccine — on the market since 2010 — is the best choice for people 65 and older. Many in that group already opt for the costlier enhanced shot. Those who get the standard vaccine are disproportionately members of ethnic and racial minorities.